Rajeev Saggar
About Rajeev Saggar
Rajeev Saggar is the Chief Medical Officer at Liquidia, with over 20 years of experience as a pulmonologist and extensive expertise in pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease.
Chief Medical Officer at Liquidia
Rajeev Saggar joined Liquidia in July 2022 as the Chief Medical Officer. He oversees all aspects of research, clinical development, medical affairs, and regulatory affairs for the company. His role is pivotal in driving the strategic direction of Liquidia's medical and clinical initiatives, contributing his vast expertise in pulmonology to the organization.
Pulmonologist with Over 20 Years of Experience
Rajeev Saggar has accumulated more than 20 years of experience as a practicing pulmonologist. His clinical expertise encompasses a wide range of respiratory conditions, with a specific focus on pulmonary arterial hypertension (PAH) and pulmonary hypertension with interstitial lung disease (PH-ILD). His extensive clinical experience enhances his ability to lead cutting-edge research and clinical development programs.
Academic and Clinical Leadership
Before joining Liquidia, Rajeev Saggar held significant academic and clinical leadership roles. He served as the Interim Chief of the Division of Pulmonary Critical Care at the University of Arizona, College of Medicine, Phoenix. Additionally, he was the Medical Director of the Pulmonary Hypertension and Fibrosis Programs and the Lung Transplant Program at Banner University Medical Center, Phoenix. These positions underscored his leadership in managing complex pulmonary conditions and advancing clinical care.
Research Contributions and Scientific Interests
Rajeev Saggar has authored more than 60 peer-reviewed publications, contributing substantially to the field of pulmonology. His scientific interests include pulmonary arterial hypertension (PAH) and pulmonary hypertension with interstitial lung disease (PH-ILD). Notably, he served as a Principal Investigator in the pivotal INSPIRE study of YUTREPIA initiated in 2018, highlighting his active involvement in groundbreaking clinical research.
Educational Background and Training
Rajeev Saggar received his M.D. degree from the University of California, Irvine, where he also completed his residency in Internal Medicine and fellowship in Pulmonary & Critical Care. He further specialized in pulmonary hypertension and lung transplantation through subspecialty training at the University of California, San Diego and the University of California, Los Angeles. This robust educational background has provided him with a solid foundation in pulmonology and critical care.